I-F型CRISPR/Cas系统与大肠埃希菌抗菌药物敏感性相关
该研究通过PCR和DNA测序检测82株抗菌药物敏感和96株多重耐药(MDR)临床大肠埃希菌分离株中I-E和I-F型CRISPR系统,发现I-F型CRISPR在敏感组(22.0%)显著高于MDR组(2.1%),且多与IncF和IncI质粒匹配,cas基因表达,提示该系统可能干扰耐药质粒获得而维持敏感性。
要点
- I-F型CRISPR在敏感大肠埃希菌中占比22.0%,显著高于MDR组的2.1%。
- 多数含I-F型CRISPR的分离株其间隔序列匹配IncF和IncI质粒。
- I-F型cas基因在野生型分离株中表达,提示CRISPR系统可能功能活跃。
核心结论
- I-F型CRISPR系统更常见于抗菌药物敏感的大肠埃希菌,可能通过干扰耐药质粒获得而维持敏感性。
研究设计与样本
- 研究纳入82株抗菌药物敏感和96株MDR临床大肠埃希菌分离株,采用PCR和DNA测序检测I-E和I-F型CRISPR系统,并进行系统发育分群、MLST和RT-PCR。
主要发现
- I-F型CRISPR与B2系统发育群相关,在敏感组占22.0%,在MDR组占2.1%,差异显著。
- 多数含I-F型CRISPR的分离株其间隔序列匹配IncF和IncI质粒。
- RT-PCR证实I-F型cas基因表达,提示系统可能具有功能。
临床怎么用
- 对于临床大肠埃希菌分离株,I-F型CRISPR的存在可能提示对多种抗菌药物敏感,但需进一步验证其预测价值。
局限性
- 原文未明确报告研究的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their associated cas genes are sequence-specific DNA nuclease systems found in bacteria and archaea. CRISPR/Cas systems use RNA transcripts of previously acquired DNA (spacers) to target invading genetic elements with the same sequence, including plasmids. In this research we studied the relationship between CRISPR/Cas systems and multidrug resistance in Escherichia coli . METHODS: The presence of Type I-E and Type I-F CRISPR systems was investigated among 82 antimicrobial-susceptible and 96 MDR clinical E. coli isolates by PCR and DNA sequencing. Phylogrouping and MLST were performed to determine relatedness of isolates. RT-PCR was performed to ascertain the expression of associated cas genes. RESULTS: Type I-F CRISPR was associated with the B2 phylogroup and was significantly overrepresented in the susceptible group (22.0%) compared with the MDR group (2.1%). The majority of CRISPR I-F-containing isolates had spacer sequences that matched IncF and IncI plasmids. RT-PCR demonstrated that Type I-F cas genes were expressed and therefore potentially functional. CONCLUSIONS: The CRISPR I-F system is more likely to be found in antimicrobial-susceptible E. coli . Given that the Type I-F system is expressed in WT isolates, we suggest that this difference could be due to the CRISPR system potentially interfering with the acquisition of antimicrobial resistance plasmids, maintaining susceptibility in these isolates.
引用
- Aydin S, Personne Y, Newire E, et al. Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli. J Antimicrob Chemother. 2017. PMID: 28535195. doi:10.1093/jac/dkx137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。